Guidelines for the programmatic management of drug-resistant tuberculosis. (Record no. 2217)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01762nam a22002297a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20191226214828.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 111017t xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9241546956 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789241546959 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | WF 310 G 2006 |
| 245 00 - TITLE STATEMENT | |
| Title | Guidelines for the programmatic management of drug-resistant tuberculosis. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Geneva : |
| Name of publisher, distributor, etc. | World Health Organization, |
| Date of publication, distribution, etc. | 2006. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | x, 174 p. : |
| Dimensions | 24 cm. |
| Other physical details | ill. ; |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | These new guidelines on the programmatic management of drug-resistant tuberculosis represent the best current knowledge in the management of drug-resistant TB and MDR-TB, and offer ample options to tailor diagnosis and care to different epidemiological and programmatic conditions worldwide. The recommendations, compiled by leading experts in the subject, should be followed without hesitation by all national programs and their partners as the most solid programmatic standards. At the same time, it is imperative to stress that the five elements of the DOTS strategy remain the cornerstone of TB control, and the most effective tool to prevent the onset and dissemination of drug resistance. Without the essential elements of TB control fully in place, management of MDR-TB will undoubtedly fail in the long term. These guidelines focus on care for MDR-TB patients, in the hope and expectation that, in future, the occurrence of massive numbers of cases can be prevented through sound TB control practices.--Publisher's description. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tuberculosis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rich, Michael. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | National Library of Medicine Classification |
| Koha item type | WHO Publications |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National Library of Medicine Classification | FNPH LIBRARY | FNPH LIBRARY | 18/10/2011 | WF 310 G 2006 | 03343 | 18/10/2011 | 18/10/2011 | WHO Publications | |||||
| National Library of Medicine Classification | FNPH LIBRARY | FNPH LIBRARY | 08/04/2013 | WF 310 G 2006 | 05894 | 08/04/2013 | 08/04/2013 | WHO Publications |